ArticleFrontiers in immunology2025

Immune biomarkers in circulating cells of NSCLC patients can effectively evaluate the efficacy of chemotherapy combined with anti-PD-1 therapy.

Jing Cao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.